X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ALEMBIC PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ALEMBIC PHARMA FULFORD INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 398.8 26.6 1,497.2% View Chart
P/BV x 6.2 6.1 102.3% View Chart
Dividend Yield % 0.1 0.8 10.9%  

Financials

 FULFORD INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ALEMBIC PHARMA
Mar-16
FULFORD INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs942792 119.0%   
Low Rs450443 101.6%   
Sales per share (Unadj.) Rs691.4167.0 413.9%  
Earnings per share (Unadj.) Rs11.538.2 30.0%  
Cash flow per share (Unadj.) Rs15.442.0 36.6%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Dividend yield (eoy) %0.30.6 44.3%  
Book value per share (Unadj.) Rs380.084.9 447.6%  
Shares outstanding (eoy) m3.90188.52 2.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.7 27.2%   
Avg P/E ratio x60.716.2 375.4%  
P/CF ratio (eoy) x45.314.7 308.2%  
Price / Book Value ratio x1.87.3 25.2%  
Dividend payout %17.410.5 166.5%   
Avg Mkt Cap Rs m2,714116,383 2.3%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5054,214 12.0%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69631,487 8.6%  
Other income Rs m12555 227.6%   
Total revenues Rs m2,82231,542 8.9%   
Gross profit Rs m-4610,060 -0.5%  
Depreciation Rs m15722 2.1%   
Interest Rs m1037 25.8%   
Profit before tax Rs m549,356 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,160 0.4%   
Profit after tax Rs m457,194 0.6%  
Gross profit margin %-1.731.9 -5.4%  
Effective tax rate %17.723.1 76.6%   
Net profit margin %1.722.8 7.3%  
BALANCE SHEET DATA
Current assets Rs m1,73815,066 11.5%   
Current liabilities Rs m5457,674 7.1%   
Net working cap to sales %44.323.5 188.6%  
Current ratio x3.22.0 162.6%  
Inventory Days Days4867 72.4%  
Debtors Days Days441 10.6%  
Net fixed assets Rs m128,237 0.1%   
Share capital Rs m39377 10.3%   
"Free" reserves Rs m1,44315,416 9.4%   
Net worth Rs m1,48216,005 9.3%   
Long term debt Rs m00-   
Total assets Rs m2,07724,594 8.4%  
Interest coverage x6.7255.2 2.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.3 101.4%   
Return on assets %2.629.4 8.9%  
Return on equity %3.044.9 6.7%  
Return on capital %4.358.7 7.3%  
Exports to sales %055.7 0.0%   
Imports to sales %24.510.4 234.5%   
Exports (fob) Rs mNA17,551 0.0%   
Imports (cif) Rs m6593,283 20.1%   
Fx inflow Rs m1717,811 0.1%   
Fx outflow Rs m6735,318 12.7%   
Net fx Rs m-65612,493 -5.3%   
CASH FLOW
From Operations Rs m909,304 1.0%  
From Investments Rs m105-3,105 -3.4%  
From Financial Activity Rs m-14-1,959 0.7%  
Net Cashflow Rs m1814,240 4.3%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 2.9 131.0%  
FIIs % 0.1 9.1 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 13.9 152.5%  
Shareholders   4,783 49,328 9.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FDC LTD.  ASTRAZENECA PHARMA  BIOCON LTD  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS